Vor Biopharma VOR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$2.45B-2,078% | -$1.66B-1,309% | -$118.6M+1.4% | ||
| $2.15M-38.3% | $2.95M-18.2% | $3.79M+4.3% | $4.69M+29.0% | $3.49M-4.0% | ||
| $25.85M+197% | $18.91M+92.1% | $13.52M+34.7% | $7.75M-29.1% | $8.7M-29.7% | ||
| -$149.89M-49.5% | -$142.71M-43.2% | -$143.98M-44.5% | -$113.6M-9.0% | -$100.26M+5.8% | ||
| $758K+119% | $941K+311% | $699K+161% | $489K-30.0% | $346K-68.2% | ||
| -$311.81M— | -$48.8M— | —— | —— | —— | ||
| $579.28M+999% | $503.81M+843% | $249.29M+153,785% | $227.79M+76,596% | $52.72M+10,137% | ||
| —— | —— | —— | —— | —— | ||
| -$150.65M-49.7% | -$143.65M-43.8% | -$144.67M-44.8% | -$114.09M-8.7% | -$100.61M+6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vor Biopharma generate?
- Vor Biopharma (VOR) generated -$149.9M in operating cash flow over the trailing twelve months.
- What is Vor Biopharma's free cash flow?
- After $758.0K of capital expenditures, Vor Biopharma's free cash flow was -$150.7M over the trailing twelve months, down 49.7% year over year.
- Where does Vor Biopharma's cash flow data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.